Emmanuel Ndashimye

Low-Frequency Drug Resistance in HIV-Infected Ugandans on Antiretroviral Treatment Is Associated with Regimen Failure

Fred Kyeyune, Richard M. Gibson, Immaculate Nankya et al. · Antimicrobial Agents and Chemotherapy · 2016 · 67 citations · Full text

Life Sciences, Pharmacotherapy, Molecular Virology +16

Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial

James Hakim, Cissy Kityo, Anne Hoppé et al. · The Lancet Infectious Diseases · 2017 · 41 citations · Full text

Pharmacy, Infectious Disease Control, Pharmacotherapy +17

Treatment failure and drug resistance is more frequent in HIV-1 subtype D versus subtype A-infected Ugandans over a 10-year study period

Fred Kyeyune, Immaculate Nankya, Samar Metha et al. · AIDS · 2013 · 38 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +15

Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial

Alexander J. Szubert, Andrew J. Prendergast, Moira Spyer et al. · PLoS Medicine · 2017 · 32 citations · Full text

Life Sciences, Infectious Diseases, Pediatrics +16

HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan Africa

Cissy Kityo, Immaculate Nankya, Anne Hoppé et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2017 · 31 citations · Full text

Life Sciences, Microbiology, Pharmacology +17